Navigation Links
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Date:7/18/2014

rice of AbbVie shares or Shire shares, significant transaction costs and/or unknown liabilities, general economic and business conditions that affect the combined companies following the consummation of the possible combination, changes in global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax laws, regulations, rates and policies, future business combinations or disposals and competitive developments. These forward-looking statements are based on numerous assumptions and assessments made in light of AbbVie's or, as the case may be, Shire's experience and perception of historical trends, current conditions, business strategies, operating environment, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this announcement could cause AbbVie's plans with respect to Shire, AbbVie's or Shire's actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this announcement are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this announcement. Additional information about economic, competitive, governmental, technological and other factors that may affect AbbVie is set forth in Item 1A, "Risk Factors," in AbbVie's 2013 Annual Report on Form 10-K, which has been filed with the SEC, the contents of which are not incorporated by reference into, nor do they
'/>"/>
SOURCE AbbVie Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
2. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
3. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
4. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
5. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
6. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
7. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
8. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
9. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
10. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
11. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015 Fibich, Leebron, Copeland, Briggs ... billion settlement has been reached to resolve lawsuits involving ... medication Actos. Actos - manufactured by Takeda Pharmaceuticals - ... bladder cancer. Several of the firm,s attorneys were instrumental ... Tommy Fibich - Founding Partner of ...
(Date:5/6/2015)... May 05, 2015 Research and Markets ... of the "Chromatography (Instruments and Reagents) Global ... their offering. Chromatography is an analytical ... component of a complex mixture by differential movement ... the scientists have considered chromatography as an esoteric ...
(Date:5/6/2015)... 6, 2015 NVSSoft, a ... named a "Cool Vendor" by top IT research firm Gartner ... Gartner defines a "Cool Vendor" as a company ... intriguing. The report highlights that, "as innovation gains ... emerging markets should look at local technologies and services, which ...
Breaking Medicine Technology:Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 4
... On February 1, 2011, the Massachusetts Institute of ... Innovation, and Engineering Systems Division will host the ... Systems Thinking from Discovery to Delivery ... by Merrimack Pharmaceuticals, will be a forum to stimulate ...
... Journal features MEPS Real Time,s Intelliguard drug management ... depending on the correct medications being dispensed. Hospitals and ... drug,s expiration dates, information about the drug administered, tracking ... would assist in preventing errors. A San ...
Cached Medicine Technology:Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 2Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 3Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 4Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 5Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 6Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 7Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium 8MEPS Real Time's New RFID Drug Management System Provides Critical Error Solution for California Hospital 2
(Date:5/6/2015)... 06, 2015 Chesapeake Regional Medical ... of Virginia to acquire Intuitive Surgical, Inc.’s latest ... system upgrade includes enhanced surgical technique capabilities, which ... across a wide spectrum of specialties. Its advancements ... and quicker recovery times. , “As the only ...
(Date:5/6/2015)... Fla. (PRWEB) May 06, 2015 ... Institute are the first in north Florida and ... technology is the latest innovation in total hip ... highly advanced, surgeon-controlled robotic arm that enables the ... Medical Center Jacksonville has offered MAKOplasty® partial knee ...
(Date:5/6/2015)... Animals make just as good friends as they ... your health. An Ohio veterinarian has been observing ... with health advantages of owning a pet. , “When animals ... pet ownership, there are proven health benefits for people-- including ... of the Animal Medical Center of Streetsboro said. ...
(Date:5/6/2015)... 06, 2015 Marketing Maven ... international water, sanitation and hygiene nonprofit by GuideStar’s Philanthropedia. ... the world and it brings our agency great joy ... Marketing Maven. “The ongoing relationship between WaterAid ... people to learn about and support the nonprofit as ...
(Date:5/6/2015)... 06, 2015 vcfo, a specialized consulting ... and operational support to optimize business performance and productivity, ... Lynch and Michael Scheaffer. Both Lynch and Scheaffer have ... experience. , “We are delighted to add Jack ... CEO. “Leveraging their background in financial management and leadership, ...
Breaking Medicine News(10 mins):Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 2Health News:Marketing Maven Expands Partnership with the #1 Ranked International Water, Sanitation and Hygiene Nonprofit 3Health News:vcfo Adds Two Senior Executives to Growing Team 2
... the American Society of Therapeutic Radiology and Oncology shows a ... takes to relieve pain from breast and prostate cancers that ... and universities in the United States and Canada were involved ... breast or prostate cancer. Patients also had bone metastasis -- ...
... feeling weak and tried, and doctors often prescribe //an ... study suggests otherwise., ,Since anemia has been associated ... treatment would make patients feel better and improve results ... German researchers , their study finds treating anemia in ...
... presented at this year’s meeting of the American Society of ... beam radiation //may be what it takes to relieve pain ... bone. ,More than 160 hospitals and universities in the ... about 900 men and women with breast or prostate cancer. ...
... road to a new and possibly better treatment for ... diabetics with oral medications to control blood sugar. They’ll ... medications are effective, but they also carry increased risk ... age. This study, published in this month’s Diabetes Care, ...
... who cheated and took the drug earlier than suggested may ... new study shows the medication works best when taken at ... is moderate to severe, as was the requirement of the ... known as serotonin agonists for the treatment of migraine have ...
... at least one common statin may be most effective ... Statins are drugs prescribed to lower cholesterol.// ,Researchers ... 10 milligrams or 20 milligrams of simvastatin, otherwise known ... or secondary prevention of coronary heart disease, stroke , ...
Cached Medicine News:
... Implants provide the surgeon with ... of the inferior and lateral ... secondary rim repair. The extended ... and extends around the lateral ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
Karate chopper, spear shaped for ease of insertion into the nucleus....
Designed to safely and easily removing a cataract nucleus, round serrated handle, dull finish....
Medicine Products: